/
AXRX
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-0.13
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.4M | $10.5M | $7.7M | $6.4M | $4.8M | $3.9M | $3.4M | $2.9M |
| Cost of revenue | $8.5M | $8.8M | $6.2M | $4.8M | $3.8M | $2.9M | $2.3M | $1.8M |
| Gross profit | $2.0M | $1.7M | $1.5M | $1.6M | $995.2K | $1.0M | $1.1M | $1.1M |
| Gross margin | 18.8% | 16.5% | 19.2% | 24.4% | 20.6% | 26.4% | 31.6% | 39.6% |
| R&D | $69.2K | $92.3K | $75.1K | $18.1K | $0 | $0 | $0 | $0 |
| Operating income | $214.6K | $249.1K | $280.1K | $314.7K | $136.4K | $117.1K | $120.1K | $136.8K |
| EBITDA | $226.8K | $252.9K | $281.0K | $521.0K | $369.0K | $117.1K | $120.1K | $136.8K |
| Net income | $111.4K | $201.4K | $216.9K | $196.0K | $74.2K | $35.8K | $11.4K | $40.3K |
| Net margin | 1.1% | 1.9% | 2.8% | 3.1% | 1.5% | 0.9% | 0.3% | 1.4% |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.00
Price
$0.00
Implied upside
+557%
Peer comparison
AMEXDRUG CORP
AMEXDRUG CORP
Held by traders on TradeandTell
No one on the platform currently holds AXRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AXRX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2012-12-03 | 20-for-1 |
Recent trades on TradeandTell
No one on the platform has traded AXRX yet.